| Date | Title | |
| 03-Dec-2012 | Covance Receives SFDA GLP Certification for Its Early Development Facility in Shanghai, China
|
Print |
| 03-Dec-2012 | Covance Earns CEO Cancer Gold Standard Employer Accreditation
|
Print |
| 12-Nov-2012 | Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
|
Print |
| 05-Nov-2012 | Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
|
Print |
| 16-Oct-2012 | Covance and NAFC Sponsor Free Medical Clinic for More Than 1,200 Patients in Dallas, Texas
|
Print |
| 05-Oct-2012 | Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2012 Financial Results Conference Call
|
Print |
| 25-Jul-2012 | Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
|
Print |
| 18-Jun-2012 | Covance Appoints Dr. Steve Street to Lead Worldwide Safety Assessment and Pharmaceutical Chemistry Services
|
Print |
| 13-Jun-2012 | Covance U.K. Sites Receive Carbon Trust Standard Accreditation
|
Print |
| 02-May-2012 | Covance Announces Executive Appointments
|
Print |
| 02-May-2012 | Covance Reports First Quarter Net Revenue Growth Of 5.7% To $531M, EPS Of $0.60, And Adjusted Net Orders Of $704M
|
Print |
| 26-Apr-2012 | Covance-BML to Expand Clinical Trial Laboratory in Japan
|
Print |
| 02-Feb-2012 | Covance and BioPontis Alliance Collaborate to Bridge Drug Development Gap
|
Print |
| 25-Jan-2012 | Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
|
Print |
| 25-Jan-2012 | Covance Board Authorizes $300 Million Stock Buyback
|
Print |
| 12-Jan-2012 | Covance, Inserm Transfert SA, and Inserm Transfert Initiative Enter Four-Year Scientific Agreement
|
Print |
| 10-Jan-2012 | Covance Microbiology Laboratory Receives ISO Accreditation
|
Print |